Which test provides the best long-term indication of glycemic control in a patient with diabetes?

Prepare for the Galen College of Nursing Exam with flashcards and multiple choice questions. Understand comprehensive explanations and get ready for your test!

Multiple Choice

Which test provides the best long-term indication of glycemic control in a patient with diabetes?

Explanation:
For measuring how well blood sugar has been controlled over months, the A1C level is the best indicator. It shows the percentage of hemoglobin that has become glycated due to circulating glucose. Because red blood cells live about 120 days, the A1C reflects average blood glucose over roughly two to three months, smoothing out day-to-day fluctuations from meals, activity, and illness. This makes it a reliable picture of long-term control rather than a single point-in-time measure. Fasting blood glucose only captures the level after an overnight fast and can miss overall trends; postprandial glucose shows spikes after meals but doesn’t convey longer-term control; a random glucose reflects recent intake and short-term factors. Thus, while those tests are useful for current status, they don’t provide the same long-term perspective as the A1C.

For measuring how well blood sugar has been controlled over months, the A1C level is the best indicator. It shows the percentage of hemoglobin that has become glycated due to circulating glucose. Because red blood cells live about 120 days, the A1C reflects average blood glucose over roughly two to three months, smoothing out day-to-day fluctuations from meals, activity, and illness. This makes it a reliable picture of long-term control rather than a single point-in-time measure.

Fasting blood glucose only captures the level after an overnight fast and can miss overall trends; postprandial glucose shows spikes after meals but doesn’t convey longer-term control; a random glucose reflects recent intake and short-term factors. Thus, while those tests are useful for current status, they don’t provide the same long-term perspective as the A1C.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy